Cytologically Proven Axillary Lymph Node Metastases Are Eradicated in Patients Receiving Preoperative Chemotherapy With Concurrent Trastuzumab for HER2-Positive Breast Cancer

BACKGROUND: The axillary pathologic complete response rate (pCR) and the effect of axillary pCR on disease-free survival (DFS) was determined in patients with HER2-positive breast cancer and biopsy-proven axillary lymph node metastases who were receiving concurrent trastuzumab and neoadjuvant chemot...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer
Auteurs principaux: Dominici, Laura S., Gonzalez, Viviana M. Negron, Buzdar, Aman U., Lucci, Anthony, Mittendorf, Elizabeth A., Le-Petross, Huong T., Babiera, Gildy V., Meric-Bernstam, Funda, Hunt, Kelly K., Kuerer, Henry M.
Format: Artigo
Langue:Inglês
Publié: 2010
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4361091/
https://ncbi.nlm.nih.gov/pubmed/20564395
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25152
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires